二肽基肽酶IV抑制剂在2型糖尿病中治疗的研究进展(4)
[15] Verspohl E J.Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors[J].Pharmacol Ther, 2009, 124(1):113-138.[16] Desai S, Brinker A, Swann J, et al.Sitagliptin-associated drug allergy: review of spontaneous adverse event reports[J].Arch Intern Med ......
您现在查看是摘要页,全文长 2588 字符。